LEQEMBI

Leqembi: US OKs maintenance dosing for Alzheimer's drug

Leqembi: US OKs monthly maintenance dosing for Alzheimer’s drug

The US Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and… Read More

Leqembi: US OKs maintenance dosing for Alzheimer's drug

Leqembi: Alzheimer’s drug from Eisai and Biogen faces setback

The European Union's drugs regulator has rejected Eisai and Biogen's Leqembi treatment for early Alzheimer's… Read More

Leqembi: US OKs maintenance dosing for Alzheimer's drug

Leqembi: Alzheimer’s drug launched in China

Eisai and Biogen have launched their Alzheimer's treatment Leqembi in China, the third country after… Read More

Leqembi: US OKs maintenance dosing for Alzheimer's drug

Leqembi: China approves Alzheimer’s treatment

Eisai and Biogen said on Tuesday that their Alzheimer's treatment Leqembi had won approval in… Read More

Leqembi: US OKs maintenance dosing for Alzheimer's drug

Leqembi: Japan approves Alzheimer treatment

Japan's Eisai said on Monday the country's health ministry had approved its Alzheimer treatment Leqembi,… Read More

Leqembi: US OKs maintenance dosing for Alzheimer's drug

Leqembi: Japan panel recommends approval of Alzheimer medicine

A Japanese health ministry panel on Monday recommended approval of the Alzheimer's disease treatment Leqembi,… Read More

Leqembi: US OKs maintenance dosing for Alzheimer's drug

LEQEMBI: Alzheimer’s drug gets US approval

Eisai and Biogen's Leqembi won a coveted standard approval nod from the U.S. Food and… Read More